InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
7
T+90 hit rate
50%
T+90 mean return
-31.0%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by PARMAR KUSH, Director. Insider active across 4 companies, notably Rallybio Corp. In total, 12 disclosures have been recorded. Breakdown: 0 buy · 7 sells. Total volume traded: €12.3m. Activity tracked since 16 November 2021. The latest transaction was filed on 7 March 2023 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
100,000 shares@ US$8.2013.0% of flowCommon StockSEC:0001209191-23-017538:0
3,153,333 sharesCommon StockSEC:0001104659-22-124136:0
99,671 shares@ US$12.504.00% mcap22.5% of flowCommon StockSEC:0001209191-22-034860:0
66,447 shares@ US$13.002.79% mcap15.7% of flowCommon StockSEC:0001209191-22-031969:0
139,539 shares@ US$13.055.49% mcap30.9% of flowCommon StockSEC:0001209191-22-008579:0
139,539 shares@ US$13.0526.9% of flowCommon StockSEC:0001209191-22-008579
238,870 shares@ US$15.300.41% mcap50.0% of flowCommon StockSEC:0001209191-21-065656:0
238,870 shares@ US$15.3050.0% of flowCommon StockSEC:0001209191-21-065656
318,616 sharesCommon StockSEC:0001104659-21-134772
318,616 sharesCommon StockSEC:0001104659-21-134772:0
2,784,626 sharesCommon StockSEC:0001209191-21-049823
2,784,626 sharesCommon StockSEC:0001209191-21-049823:0
12 of 12 declarations
About PARMAR KUSH
Kush Parmar is a Board Member at Rallybio Corp, Entrada Therapeutics, Inc., and Vor Biopharma Inc. He contributes to corporate governance and oversight of operations. Kush is involved in strategic decisions that influence the performance of these companies.
